Glycans in Drug Design

Glycans are constituents of many bio-therapeutic agents, extending from natural products to molecules based on rational design to recombinant glycoproteins. The glycan constituents of these agents can be significant factors of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology encompasses a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some other plant proteins that are capable of relating with endogenous or foreign (macro) molecules. The importance of the research is on protein-carbohydrate interaction and their contribution in signalling processes in plants or in plant protection. Based on the generated fundamental awareness new approaches are being developed to shield crop plants against pests and diseases.


  • Screening and drug design
  • Biomarkers in drug design
  • Protein–ligand and protein–protein interactions
  • Drug delivery using Nanotechnology
  • Proteome mapping

Related Conference of Glycans in Drug Design

May 10-11, 2019

13th International Conference on Proteomics, Genomics and Bioinformatics

| Radisson Hotel Narita | Tokyo, Japan
May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
May 17-18, 2019

2nd International Conference on Computational Biology and Bioinformatics

| Holiday Inn Singapore Atrium | Singapore
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Glycans in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in